Acute Budd-Chiari syndrome associated with activated protein C resistance during intravenous anticoagulant treatment

---

Atıf İçin Kopyala

YILDIZ O. B., Oran B., Buyukasik Y., Haznedaroglu I., Cekirge S., Kirazli S.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, cilt.4, sa.3, ss.220-223, 1998 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 4 Sayı: 3
• Basım Tarihi: 1998
• Doi Numarası: 10.1177/107602969800400315
• Dergi Adı: CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.220-223
• Hacettepe Üniversitesi Adresli: Hayır

Özet

The Budd-Chiari syndrome is a rare but serious condition defined as hepatic venous outflow obstruction. This article presents a case of acute Budd-Chiari syndrome in a 13-year-old woman with activated protein C resistance while she was bring treated with intravenous heparin infusion for previously documented deep venous thrombosis. Activated protein C resistance caused by factor V Leiden mutation has emerged as the most prevalent hereditary cause of venous thromboembolism and should be considered as an etiologic factor in patients with Budd-Chiari syndrome.